FMA
IPCI

FNY Managed Accounts’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

FNY Managed Accounts’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$1K Buy
+210
New +$1.52K ﹤0.01% 573
2017
Q4 		– Sell
-100
Closed – – 915
2017
Q3 		$0 Buy
+100
New +$1.43K ﹤0.01% 724

Other funds holding IPCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $2.95B AUM 22.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return
VAM
Verity Asset Management Durham, North Carolina $238M AUM 24.8% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FNY Managed Accounts's IPCI Position: Q1 2018 in Review

FNY Managed Accounts opened a new position in Intellipharmaceuticals International Inc. (IPCI) in Q1 2018: 210 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #573 among its holdings. This is a return to the name: FNY Managed Accounts previously reported a position in IPCI as recently as Q3 2017.

FNY Managed Accounts first reported a position in IPCI in Q3 2017 and has held it in 2 quarters since. 24 funds tracked by Wall St. Rank hold IPCI as of Q1 2018.

  • FNY Managed Accounts held 210 shares of Intellipharmaceuticals International Inc. worth $1K as of Q1 2018.
  • Intellipharmaceuticals International Inc. was a new FNY Managed Accounts position in Q1 2018.
  • Intellipharmaceuticals International Inc. made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #573 holding.
  • FNY Managed Accounts first reported a position in Intellipharmaceuticals International Inc. in Q3 2017 and has held it in 2 quarters since.
  • 24 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.